- Trials with a EudraCT protocol (1,068)
- Paediatric studies in scope of Art45 of the Paediatric Regulation (73)
1,068 result(s) found for: Corticosteroid.
Displaying page 1 of 54.
EudraCT Number: 2014-001391-54 | Sponsor Protocol Number: D2210C00013 | Start Date*: 2015-01-23 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Multicentre, Randomized, Double-blind, Parallel Group, Placebo Controlled, Phase 3 Study to Evaluate the Efficacy and Safety of Tralokinumab in Reducing Oral Corticosteroid Use in Adults and Adol... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) NL (Completed) BE (Completed) FR (Completed) PL (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2016-002584-33 | Sponsor Protocol Number: CINC424C2301 | Start Date*: 2017-01-23 | ||||||||||||||||||||||||||
Sponsor Name:Novartis Pharma Services AG | ||||||||||||||||||||||||||||
Full Title: A phase III randomized open-label multi-center study of ruxolitinib vs. best available therapy in patients with corticosteroid-refractory acute graft vs. host disease after allogenic stem cell tran... | ||||||||||||||||||||||||||||
Medical condition: corticosteroid-refractory acute graft vs. host disease after allogeneic stem cell transplantation | ||||||||||||||||||||||||||||
|
||||||||||||||||||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | |||||||||||||||||||||||||||
Trial protocol: DE (Completed) IT (Completed) ES (Completed) AT (Completed) FR (Completed) NO (Completed) SE (Completed) DK (Completed) GB (GB - no longer in EU/EEA) CZ (Completed) PT (Completed) HU (Completed) BG (Completed) PL (Completed) NL (Completed) GR (Completed) | ||||||||||||||||||||||||||||
Trial results: View results |
EudraCT Number: 2019-003742-32 | Sponsor Protocol Number: N/A | Start Date*: 2020-01-17 | |||||||||||
Sponsor Name:University Hospitals Plymouth NHS Trust | |||||||||||||
Full Title: The Soft Tissue Injection of Corticosteroid And Local anaesthetic Study - A Single site, non-inferiority randomised control trial evaluating pain after soft tissue corticosteroid injections with an... | |||||||||||||
Medical condition: Trigger finger De Quervains tenosynovitis Carpal tunnel syndrome | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (GB - no longer in EU/EEA) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2015-003441-26 | Sponsor Protocol Number: Protocol_CORTICO-COP_PSJUJ | Start Date*: 2016-03-02 | |||||||||||
Sponsor Name:Chronic Obstructive Pulmonary Disease Trial Network (COP:TRIN) | |||||||||||||
Full Title: CORTICO-COP (CORTICOsteroid reduction in COPD) trial | |||||||||||||
Medical condition: 1) Whether a reduction of the dose systemic corticosteroids (SC) therapy in patients with acute exacerbation of COPD(AE-COPD) - compared with AE-COPD patients in the standard treatment- leading to ... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DK (Completed) | |||||||||||||
Trial results: View results |
EudraCT Number: 2019-002068-29 | Sponsor Protocol Number: ANCA_CGM | Start Date*: 2019-10-24 |
Sponsor Name:Medizinische Universität Graz, Universitätsklinik für Innere Medizin, Klinische Abteilung für Nephrologie | ||
Full Title: Influence of once vs twice daily corticosteroid administration on glycemia assessed by continuous glucose monitoring in patients with ANCA vasculitis | ||
Medical condition: ANCA vasculitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: AT (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2008-001257-18 | Sponsor Protocol Number: 16400076 | Start Date*: 2008-07-14 |
Sponsor Name:Biomet Nederland BV | ||
Full Title: Use of PRP to treat plantar fasciitis, blinded and randomized as a multi center study | ||
Medical condition: Patients with plantar fasciitis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-003171-35 | Sponsor Protocol Number: IgPro20_3007 | Start Date*: 2019-09-24 | |||||||||||
Sponsor Name:CSL Behring LLC | |||||||||||||
Full Title: A Study to Evaluate the Efficacy, Safety, and Pharmacokinetics of IgPro20 (Subcutaneous Immunoglobulin, Hizentra®) in Adults with Dermatomyositis (DM) | |||||||||||||
Medical condition: Dermatomyositis | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: FR (Trial now transitioned) DE (Trial now transitioned) BE (Trial now transitioned) IT (Ongoing) HU (Trial now transitioned) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-001431-40 | Sponsor Protocol Number: 5101126 | Start Date*: 2018-08-01 |
Sponsor Name:Kuopio University Hospital | ||
Full Title: Does postoperative corticosteroid management prevent atrial fibrillation after mitral valve surgery? | ||
Medical condition: new onset atrial fibrallation and paroxysmal atrial fibrillation | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2006-000582-11 | Sponsor Protocol Number: 251106BS | Start Date*: 2006-07-14 |
Sponsor Name:ALTANA Inc | ||
Full Title: Determination of anti-inflammatory efficacy of topical formulations in a UV erythema test | ||
Medical condition: Healthy subjects will be included in the study. The new generic formulation is intended to be used in the topical treatment of inflammatory processes. | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: DE (Completed) | ||
Trial results: (No results available) |
EudraCT Number: 2009-018187-10 | Sponsor Protocol Number: DODO1011 | Start Date*: 2010-04-21 |
Sponsor Name:Ziekenhuisgroep Twente | ||
Full Title: Double dose treatment: Corticosteroid injection therapy in arthritis | ||
Medical condition: To determine whether doubling the dose of triamcinolone injections in the treatment of arthritis in knee joints is more effective, both in number of responding patients and in duration of response ... | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: NL (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-001170-15 | Sponsor Protocol Number: CECUM | Start Date*: 2017-10-19 |
Sponsor Name:GETECCU (Grupo Español de Trabajo en Enfermedad de Crohn y Colitis ulcerosa) | ||
Full Title: Efficacy of high-dose corticosteroid pulses added to conventional oral corticosteroid course in comparison with monotherapy oral corticosteroid course for moderate flares of ulcerative colitis: a... | ||
Medical condition: Moderate flares of Ulcerative Colitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: ES (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2016-004514-10 | Sponsor Protocol Number: 00173 | Start Date*: 2017-03-08 |
Sponsor Name:Raimo Tuuminen | ||
Full Title: Pre and post-operative corticosteroid and NSAID combination treatment in cataract surgery of diabetic patient | ||
Medical condition: Cataract senilis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-004083-62 | Sponsor Protocol Number: steroid3848 | Start Date*: 2019-09-06 |
Sponsor Name:Semmelweis University, Oro-Maxillofacial Surgery and Stomatology | ||
Full Title: Effect of preoperative intramasseteric methylprednisolone injection on the post-operative sequelae of lower third molar surgery: a placebo controlled, randomized, double-blinded study | ||
Medical condition: post-operative swelling, trismus, pain | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: HU (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2004-000248-25 | Sponsor Protocol Number: CZOL446O2306 | Start Date*: 2004-08-04 |
Sponsor Name:Novartis Pharma AG | ||
Full Title: A multinational, multicenter, randomized, double-blind, double-dummy, stratified, active controlled parallel group study comparing the efficacy and safety of intravenous zoledronic acid, 5 mg once ... | ||
Medical condition: corticosteroid induced osteoporosis | ||
Disease: | ||
Population Age: Adults, Elderly | Gender: Male, Female | |
Trial protocol: HU (Completed) CZ (Completed) ES (Completed) | ||
Trial results: View results |
EudraCT Number: 2021-006497-23 | Sponsor Protocol Number: 870128 | Start Date*: 2022-07-05 |
Sponsor Name:Helsinki University Hospital | ||
Full Title: Corticosteroid in treatment of acute laryngitis among vocal professionals | ||
Medical condition: Laryngitis | ||
Disease: | ||
Population Age: Adults | Gender: Male, Female | |
Trial protocol: FI (Ongoing) | ||
Trial results: (No results available) |
EudraCT Number: 2018-000170-30 | Sponsor Protocol Number: D3250C00065 | Start Date*: 2018-10-17 | |||||||||||
Sponsor Name:AstraZeneca AB | |||||||||||||
Full Title: A Multicenter, Open-label, Phase 3b Efficacy and Safety Study of Benralizumab 30 mg Administered Subcutaneously to Reduce Oral Corticosteroid Use in Adult Patients with Severe Eosinophilic Asthma o... | |||||||||||||
Medical condition: Severe Eosinophilic Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) DK (Completed) SE (Completed) ES (Ongoing) PL (Completed) BE (Completed) GB (GB - no longer in EU/EEA) IT (Ongoing) | |||||||||||||
Trial results: View results |
EudraCT Number: 2017-004872-76 | Sponsor Protocol Number: RECUT-Trial | Start Date*: 2020-05-07 | |||||||||||
Sponsor Name:Medizinische Universtitätsklinik, Kantonsspital Baselland | |||||||||||||
Full Title: Reduction of corticosteroid use in outpatient treatment of exacerbated COPD – a randomized, double-blind, non-inferiority study (The “RECUT”-Trial) | |||||||||||||
Medical condition: acute exacerbation of COPD; acute exacerbation (defined solely by clinical parameters according to the Anthonisen criteria, meaning ≥2 of the following: change of baseline dyspnea, change of cough,... | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2017-002214-31 | Sponsor Protocol Number: XmAb5871-06 | Start Date*: Information not available in EudraCT | |||||||||||
Sponsor Name:Xencor, Inc. | |||||||||||||
Full Title: A Phase 3, Multicenter, Randomized, Double-Blind, Placebo-Controlled Study to Evaluate the Efficacy and Safety of XmAb®5871 in Patients with IgG4-Related Disease (INDIGO) | |||||||||||||
Medical condition: IgG4-Related Disease | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: GB (Prematurely Ended) NL (Prematurely Ended) SE (Prematurely Ended) BE (Completed) IT (Prematurely Ended) | |||||||||||||
Trial results: View results |
EudraCT Number: 2006-006545-13 | Sponsor Protocol Number: LX211-03-UV | Start Date*: 2007-04-27 | |||||||||||
Sponsor Name:Lux Biosciences GmbH | |||||||||||||
Full Title: A Double-Masked, Placebo-Controlled, Multi-Centre, Dose-Ranging Study to Assess the Efficacy and Safety of LX211 as Therapy in Subjects with Active Sight Threatening, Non-Infectious Uveitis. | |||||||||||||
Medical condition: Subjects with active sight-threatening, non-infectious anterior, anterior and intermediate- or panuveitis who require systemic immunosuppression for the control of their disease. | |||||||||||||
|
|||||||||||||
Population Age: Adolescents, Under 18, Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Completed) FR (Completed) GB (Completed) AT (Completed) | |||||||||||||
Trial results: (No results available) |
EudraCT Number: 2018-000212-25 | Sponsor Protocol Number: CQAW039A2323 | Start Date*: 2018-12-27 | |||||||||||
Sponsor Name:Novartis Pharma AG | |||||||||||||
Full Title: A 52-week, multicenter, randomized, double-blind, double-dummy, parallel-group, placebo-controlled study of fevipiprant once daily plus standard-of-care (SoC) for reduction of systemic corticostero... | |||||||||||||
Medical condition: Asthma | |||||||||||||
|
|||||||||||||
Population Age: Adults, Elderly | Gender: Male, Female | ||||||||||||
Trial protocol: DE (Prematurely Ended) GB (Prematurely Ended) CZ (Completed) SK (Prematurely Ended) ES (Prematurely Ended) BE (Prematurely Ended) FR (Completed) GR (Completed) BG (Prematurely Ended) HU (Prematurely Ended) | |||||||||||||
Trial results: View results |
Subscribe to this Search
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
To subscribe to the RSS feed for this search click here . This will provide an RSS feed for clinical trials matching your search that have been added or updated in the last 7 days.
Download Options: | |
---|---|
Number of Trials to download: | |
Download Content: | |
Download Format: | |
Note, where multi-state trials are shown in search results, selecting "Full Trial details" will download full information for each of the member states/countries involved in the trial. |
Query did not match any studies.